Helicobacter Pylori Diagnostics Market Review, Outlook, Future Analysis And Synthesis By 2026 Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six individuals infected with H. pylori are expected to eventually develop peptic ulcer disease. Infected individuals experience long asymptomatic conditions with nearly 70% of individuals having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc. Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which are obtained through endoscopy and used for biopsy or noninvasive tests that requires blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas non-invasive includes stool antigen assays serology tests and urea breath test. The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026). Get In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/1874 Increasing prevalence of helicobacter pylori Helicobacter pylori diagnostics market growth in emerging economies is propelling the Prevalence of helicobacter pylori is declining in developed countries, whereas its prevalence in emerging economies is increasing. For instance, according to the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), 2017, around 4.4 billion people worldwide are infected with Helicobacter pylori (H. pylori). Furthermore, same source suggested that prevalence in Africa is up to 80%, which is the highest globally, while in Asia, over 50% of the population was infected with H. pylori. Moreover, according to the International Agency for Research on Cancer report 2014, in 2012, around 952,000 new gastric cancer cases occurred globally and around 734,000 gastric cancers were estimated to occur due to H. pylori infection. Such high prevalence of Helicobacter pylori in Africa and Asia is expected to fuel the regional helicobacter market growth. Africa market to exhibit fastest growth over the forecast period Regionally, Helicobacter pylori diagnostics market is segmented into - North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America Helicobacter pylori diagnostic market holds dominant position in the global market and this is attributed to initiatives to provide test kits at low costs to eradicate H. pylori infection. For instance, antibody-based detection tests are available at lower cost for enhancing the eradication of helicobacter pylori infection in Quebec. Moreover, Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), an independent body reporting to the Quebec Minister of Health and Social Services, recommends the 13C-urea breath test to be made available in all areas of Québec. However, Africa Helicobacter pylori diagnostic market is expected to exhibit high CAGR, owing to high prevalence of Helicobacter pylori. According to studies published in Gastroenterology Journal, 2017, the data suggested that Africa has highest prevalence of H. pylori infection, which is around 79%. Report includes chapters which deeply display the following deliverable about industry : • Helicobacter Pylori Diagnostics Market Research Objective and Assumption • Helicobacter Pylori Diagnostics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Helicobacter Pylori Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Helicobacter Pylori Diagnostics Market, By Regions • Helicobacter Pylori Diagnostics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Helicobacter Pylori Diagnostics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Helicobacter Pylori Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Helicobacter Pylori Diagnostics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Inorganic strategies by key players is fuelling growth of the Helicobacter pylori diagnostics market Key players involved in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc. Detailed Segmentation: Global Helicobacter Pylori Diagnostics Market, By Test Type: • Invasive • Immunoassay • Rapid Urease Test • Histology • Non-invasive • Stool Antigen Assays • Serology Tests • Urea Breath Test Global Helicobacter Pylori Diagnostics Market, By End User: • Hospitals • Clinics • Diagnostic Laboratories • Others Global Helicobacter Pylori Diagnostics Market, By Region: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa Else place an Inquire before Purchase “Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2026": https://www.coherentmarketinsights.com/insight/talk-toanalyst/1874 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).
© Copyright 2024 Paperzz
